ASTRAZENECA CEDEAR EACH REP 0.5 ADR USD0.25ASTRAZENECA CEDEAR EACH REP 0.5 ADR USD0.25ASTRAZENECA CEDEAR EACH REP 0.5 ADR USD0.25

ASTRAZENECA CEDEAR EACH REP 0.5 ADR USD0.25

No trades
See on Supercharts

Key facts today


As of July 31, 2025, AstraZeneca PLC has 1,550,682,580 ordinary shares valued at US$0.25 each, with no shares in Treasury, meeting UK disclosure rules.
Analyze the impactAnalyze the impact
Market capitalization
‪231.77 B‬USD
0.95USD
‪6.25 B‬USD
‪48.03 B‬USD
Beta (1Y)
−0.02

About AstraZeneca PLC


CEO
Pascal Soriot
Headquarters
Cambridge
Founded
1992
ISIN
ARDEUT112489
FIGI
BBG000DDGDV6
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Check out other big names from the same industry as AZNC.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

US46353AX6
ASTRAZENECA 20/50
Yield to maturity
7.10%
Maturity date
Aug 6, 2050
US46353AZ1
ASTRAZENECA 21/51
Yield to maturity
6.47%
Maturity date
May 28, 2051
US46353AU2
ASTRAZENECA 18/48
Yield to maturity
5.76%
Maturity date
Aug 17, 2048
US46353AM0
ASTRAZENECA PLC 15/45
Yield to maturity
5.71%
Maturity date
Nov 16, 2045
AZN3901525
AstraZeneca PLC 4.0% 18-SEP-2042
Yield to maturity
5.49%
Maturity date
Sep 18, 2042
AZN.GE
AstraZeneca PLC 6.45% 15-SEP-2037
Yield to maturity
4.83%
Maturity date
Sep 15, 2037
US46353AL2
ASTRAZENECA PLC 15/25
Yield to maturity
4.83%
Maturity date
Nov 16, 2025
US46353AW8
ASTRAZENECA 20/30
Yield to maturity
4.72%
Maturity date
Aug 6, 2030
A
US4636NAN3
ASTRAZEN.FI. 24/34
Yield to maturity
4.71%
Maturity date
Feb 26, 2034
A
AZN5549116
AstraZeneca Finance LLC 4.875% 03-MAR-2033
Yield to maturity
4.52%
Maturity date
Mar 3, 2033
A
US4636NAA1
ASTRAZEN.FI. 21/26
Yield to maturity
4.49%
Maturity date
May 28, 2026

See all AZNC bonds